| 1-chloro-2,4-dinitrobenzene | affects expression | EXP | | 6480464 | Dinitrochlorobenzene affects the expression of MKI67 mRNA | CTD | PMID:22302311 |
| 17alpha-ethynylestradiol | affects expression | ISO | RGD:1305476 | 6480464 | Ethinyl Estradiol affects the expression of MKI67 mRNA | CTD | PMID:17351261 |
| 17beta-estradiol | increases expression | EXP | | 6480464 | Estradiol results in increased expression of MKI67 protein | CTD | PMID:15845746 PMID:19654927 |
| 17beta-estradiol | increases expression | ISO | RGD:1313525 | 6480464 | Estradiol results in increased expression of MKI67 mRNA | CTD | PMID:19167446 |
| 17beta-estradiol | multiple interactions | ISO | RGD:1305476 | 6480464 | Isoflavones inhibits the reaction [Estradiol results in increased expression of MKI67 mRNA] | CTD | PMID:20381596 |
| 17beta-estradiol | increases expression | ISO | RGD:1305476 | 6480464 | Estradiol results in increased expression of MKI67 mRNA | CTD | PMID:20381596 |
| 17beta-estradiol | multiple interactions | EXP | | 6480464 | SOD2 protein affects the reaction [Estradiol deficiency results in increased expression of MKI67 protein] | CTD | PMID:21484412 |
| 17beta-estradiol | increases expression | EXP | | 6480464 | Estradiol deficiency results in increased expression of MKI67 protein | CTD | PMID:21484412 |
| 17beta-estradiol | increases expression | EXP | | 6480464 | Estradiol results in increased expression of MKI67 protein | CTD | PMID:19654927 PMID:15845746 |
| 17beta-estradiol | increases expression | ISO | RGD:1305476 | 6480464 | Estradiol results in increased expression of MKI67 protein | CTD | PMID:16607101 |
| 17beta-estradiol | multiple interactions | ISO | RGD:1305476 | 6480464 | [Estradiol co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of MKI67 protein | CTD | PMID:16891317 |
| 17beta-estradiol | multiple interactions | EXP | | 6480464 | Lithium Chloride inhibits the reaction [Progesterone inhibits the reaction [Estradiol results in increased expression of MKI67 protein]] | CTD | PMID:15845746 |
| 17beta-estradiol | increases expression | EXP | | 6480464 | Estradiol results in increased expression of MKI67 protein | CTD | PMID:15845746 |
| 17beta-estradiol | increases expression | ISO | RGD:1313525 | 6480464 | Estradiol results in increased expression of MKI67 mRNA | CTD | PMID:18310284 PMID:19167446 |
| 17beta-estradiol | multiple interactions | EXP | | 6480464 | fulvestrant inhibits the reaction [Estradiol results in increased expression of MKI67 protein] | CTD | PMID:19654927 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of MKI67 mRNA | CTD | PMID:18691609 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | EXP | | 6480464 | Tetrachlorodibenzodioxin promotes the reaction [NFE2L2 gene mutant form results in increased expression of MKI67 protein] | CTD | PMID:21846477 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of MKI67 mRNA | CTD | PMID:21846477 |
| 2,4,6-trinitrobenzenesulfonic acid | increases expression | EXP | | 6480464 | Trinitrobenzenesulfonic Acid results in increased expression of MKI67 mRNA | CTD | PMID:17982090 |
| 2-acetamidofluorene | multiple interactions | ISO | RGD:1305476 | 6480464 | Vanadium inhibits the reaction [2-Acetylaminofluorene results in increased expression of MKI67 protein] | CTD | PMID:15565650 |
| 2-acetamidofluorene | increases expression | EXP | | 6480464 | 2-Acetylaminofluorene results in increased expression of MKI67 mRNA | CTD | PMID:17317680 |
| 2-acetamidofluorene | multiple interactions | ISO | RGD:1305476 | 6480464 | [Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of MKI67 protein | CTD | PMID:17393424 |
| 2-acetamidofluorene | increases expression | ISO | RGD:1305476 | 6480464 | 2-Acetylaminofluorene results in increased expression of MKI67 protein | CTD | PMID:15565650 |
| 2-amino-2-deoxy-D-glucopyranose | decreases expression | ISO | RGD:1305476 | 6480464 | Glucosamine results in decreased expression of MKI67 mRNA | CTD | PMID:17109745 |
| 3-methylcholanthrene | increases expression | EXP | | 6480464 | Methylcholanthrene results in increased expression of MKI67 mRNA | CTD | PMID:20713471 |
| 3-nitropropanoic acid | decreases expression | ISO | RGD:1305476 | 6480464 | 3-nitropropionic acid results in decreased expression of MKI67 protein | CTD | PMID:21827787 |
| 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one | increases expression | ISO | RGD:1313525 | 6480464 | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of MKI67 protein | CTD | PMID:21776270 |
| 4-hydroxynon-2-enal | decreases expression | EXP | | 6480464 | 4-hydroxy-2-nonenal results in decreased expression of MKI67 mRNA | CTD | PMID:19191707 |
| 5-aza-2'-deoxycytidine | multiple interactions | ISO | RGD:1305476 | 6480464 | decitabine inhibits the reaction [Cadmium Chloride results in increased expression of MKI67 protein] | CTD | PMID:22457795 |
| 5-azacytidine | multiple interactions | ISO | RGD:1313525 | 6480464 | [Azacitidine co-treated with Thalidomide] affects the expression of MKI67 mRNA | CTD | PMID:18720364 |
| 5-fluorouracil | affects response to substance | ISO | RGD:1313525 | 6480464 | MKI67 mRNA affects the susceptibility to Fluorouracil | CTD | PMID:18286688 |
| 5-fluorouracil | decreases expression | ISO | RGD:1313525 | 6480464 | Fluorouracil results in decreased expression of MKI67 mRNA | CTD | PMID:16709241 PMID:15205334 |
| 5-fluorouracil | decreases expression | ISO | RGD:1313525 | 6480464 | Fluorouracil results in decreased expression of MKI67 | CTD | PMID:11300326 PMID:21594360 |
| 5-fluorouracil | affects response to substance | ISO | RGD:1313525 | 6480464 | MKI67 protein affects the susceptibility to Fluorouracil | CTD | PMID:15548681 |
| 5-fluorouracil | decreases expression | ISO | RGD:1313525 | 6480464 | Fluorouracil results in decreased expression of MKI67 mRNA | CTD | PMID:15205334 PMID:16709241 |
| 5-fluorouracil | decreases expression | ISO | RGD:1313525 | 6480464 | Fluorouracil results in decreased expression of MKI67 | CTD | PMID:21594360 PMID:11300326 |
| 6-propyl-2-thiouracil | multiple interactions | ISO | RGD:1305476 | 6480464 | Copper inhibits the reaction [[diisopropanolnitrosamine co-treated with Propylthiouracil] results in increased expression of MKI67 protein]; more ... | CTD | PMID:19497425 |
| 7,12-dimethyltetraphene | multiple interactions | ISO | RGD:1305476 | 6480464 | [Estradiol co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of MKI67 protein | CTD | PMID:16891317 |
| acrylamide | decreases expression | ISO | RGD:1313525 | 6480464 | Acrylamide results in decreased expression of MKI67 protein | CTD | PMID:20734998 |
| aflatoxin B1 | affects expression | ISO | RGD:1313525 | 6480464 | Aflatoxin B1 affects the expression of MKI67 protein | CTD | PMID:20106945 |
| aflatoxin B1 | decreases expression | ISO | RGD:1313525 | 6480464 | Aflatoxin B1 results in decreased expression of MKI67 mRNA | CTD | PMID:21641981 |
| aflatoxin B1 | decreases expression | EXP | | 6480464 | Aflatoxin B1 results in decreased expression of MKI67 mRNA | CTD | PMID:19770486 |
| aldehydo-D-glucosamine | decreases expression | ISO | RGD:1305476 | 6480464 | Glucosamine results in decreased expression of MKI67 mRNA | CTD | PMID:17109745 |
| all-trans-retinoic acid | decreases expression | ISO | RGD:1313525 | 6480464 | Tretinoin results in decreased expression of MKI67 protein | CTD | PMID:16461808 |
| all-trans-retinoic acid | multiple interactions | ISO | RGD:1305476 | 6480464 | Tretinoin inhibits the reaction [sodium arsenite results in decreased expression of MKI67 protein] | CTD | PMID:21964460 |
| all-trans-retinoic acid | decreases expression | ISO | RGD:1313525 | 6480464 | Tretinoin results in decreased expression of MKI67 mRNA | CTD | PMID:16249480 |
| alpha-hexylcinnamaldehyde | affects expression | EXP | | 6480464 | hexyl cinnamic aldehyde affects the expression of MKI67 mRNA | CTD | PMID:22302311 |
| aminoguanidine | decreases expression | ISO | RGD:1313525 | 6480464 | pimagedine results in decreased expression of MKI67 mRNA | CTD | PMID:19266598 |
| anastrozole | decreases expression | ISO | RGD:1313525 | 6480464 | anastrozole results in decreased expression of MKI67 protein | CTD | PMID:15767642 PMID:16002280 |
| anastrozole | decreases expression | ISO | RGD:1313525 | 6480464 | anastrozole results in decreased expression of MKI67 protein | CTD | PMID:16002280 PMID:15767642 |
| anastrozole | multiple interactions | ISO | RGD:1313525 | 6480464 | [Tamoxifen co-treated with anastrozole] results in decreased expression of MKI67 protein | CTD | PMID:15767642 |
| aniline | increases expression | ISO | RGD:1305476 | 6480464 | aniline results in increased expression of MKI67 protein | CTD | PMID:21070798 |
| atrazine | multiple interactions | ISO | RGD:1313525 | 6480464 | [Atrazine co-treated with Arsenates] results in increased expression of MKI67 mRNA | CTD | PMID:18585445 |
| benzene | decreases expression | ISO | RGD:1313525 | 6480464 | Benzene results in decreased expression of MKI67 mRNA | CTD | PMID:21843810 |
| benzo[a]pyrene | decreases expression | EXP | | 6480464 | Benzo(a)pyrene results in decreased expression of MKI67 mRNA | CTD | PMID:19770486 more ... |
| benzo[a]pyrene | decreases expression | EXP | | 6480464 | Benzo(a)pyrene results in decreased expression of MKI67 mRNA | CTD | PMID:17942131 more ... |
| benzo[a]pyrene | decreases expression | EXP | | 6480464 | Benzo(a)pyrene results in decreased expression of MKI67 mRNA | CTD | PMID:17942131 more ... |
| benzo[a]pyrene | decreases expression | EXP | | 6480464 | Benzo(a)pyrene results in decreased expression of MKI67 mRNA | CTD | PMID:19770486 more ... |
| benzo[a]pyrene | decreases expression | EXP | | 6480464 | Benzo(a)pyrene results in decreased expression of MKI67 mRNA | CTD | PMID:17942131 PMID:19770486 |
| benzo[a]pyrene | decreases expression | EXP | | 6480464 | Benzo(a)pyrene results in decreased expression of MKI67 mRNA | CTD | PMID:17942131 |
| benzo[a]pyrene | increases expression | EXP | | 6480464 | Benzo(a)pyrene results in increased expression of MKI67 mRNA | CTD | PMID:20713471 |
| benzo[b]fluoranthene | increases expression | ISO | RGD:1313525 | 6480464 | benzo(b)fluoranthene results in increased expression of MKI67 protein | CTD | PMID:21776270 |
| beta-D-glucosamine | decreases expression | ISO | RGD:1305476 | 6480464 | Glucosamine results in decreased expression of MKI67 mRNA | CTD | PMID:17109745 |
| bicalutamide | decreases expression | ISO | RGD:1313525 | 6480464 | bicalutamide results in decreased expression of MKI67 mRNA | CTD | PMID:15638997 |
| bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of MKI67 mRNA; more ... | CTD | PMID:22875908 |
| bisphenol A | decreases expression | ISO | RGD:1305476 | 6480464 | bisphenol A results in decreased expression of MKI67 mRNA | CTD | PMID:23146694 |
| bucladesine | decreases expression | ISO | RGD:1305476 | 6480464 | Bucladesine results in decreased expression of MKI67 protein | CTD | PMID:16718685 |
| cadmium dichloride | multiple interactions | ISO | RGD:1305476 | 6480464 | decitabine inhibits the reaction [Cadmium Chloride results in increased expression of MKI67 protein] | CTD | PMID:22457795 |
| cadmium dichloride | increases expression | ISO | RGD:1305476 | 6480464 | Cadmium Chloride results in increased expression of MKI67 protein | CTD | PMID:22081424 PMID:22457795 |
| calcitriol | decreases expression | ISO | RGD:1313525 | 6480464 | Calcitriol results in decreased expression of MKI67 mRNA | CTD | PMID:21592394 |
| calcitriol | decreases expression | ISO | RGD:1313525 | 6480464 | Calcitriol results in decreased expression of MKI67 protein | CTD | PMID:8950452 |
| calcitriol | multiple interactions | ISO | RGD:1313525 | 6480464 | [Testosterone co-treated with Calcitriol] results in decreased expression of MKI67 mRNA | CTD | PMID:21592394 |
| cefaloridine | decreases expression | ISO | RGD:1305476 | 6480464 | Cephaloridine results in decreased expression of MKI67 mRNA | CTD | PMID:18500788 |
| celecoxib | decreases expression | ISO | RGD:1313525 | 6480464 | celecoxib results in decreased expression of MKI67 | CTD | PMID:20697803 |
| celecoxib | multiple interactions | ISO | RGD:1313525 | 6480464 | [FEC protocol co-treated with celecoxib] results in decreased expression of MKI67 protein | CTD | PMID:16507397 |
| chlorpromazine | decreases expression | ISO | RGD:1313525 | 6480464 | Chlorpromazine analog results in decreased expression of MKI67 mRNA | CTD | PMID:15924885 |
| choline | multiple interactions | EXP | | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of MKI67 mRNA | CTD | PMID:20938992 |
| ciglitazone | multiple interactions | ISO | RGD:1313525 | 6480464 | [ciglitazone binds to PPARG protein alternative form] which results in increased expression of MKI67 mRNA | CTD | PMID:16197558 |
| cisplatin | increases phosphorylation | EXP | | 6480464 | Cisplatin results in increased phosphorylation of MKI67 protein | CTD | PMID:22006019 |
| cisplatin | increases expression | EXP | | 6480464 | Cisplatin results in increased expression of MKI67 protein | CTD | PMID:20702592 |
| cobalt dichloride | decreases expression | ISO | RGD:1313525 | 6480464 | cobaltous chloride results in decreased expression of MKI67 mRNA | CTD | PMID:19376846 PMID:19320972 |
| cobalt dichloride | decreases expression | ISO | RGD:1313525 | 6480464 | cobaltous chloride results in decreased expression of MKI67 mRNA | CTD | PMID:19320972 PMID:19376846 |
| copper atom | multiple interactions | ISO | RGD:1305476 | 6480464 | Copper inhibits the reaction [[diisopropanolnitrosamine co-treated with Propylthiouracil] results in increased expression of MKI67 protein]; more ... | CTD | PMID:19497425 |
| copper atom | multiple interactions | ISO | RGD:1313525 | 6480464 | [NSC 689534 binds to Copper] which results in decreased expression of MKI67 mRNA | CTD | PMID:20971185 |
| copper(0) | multiple interactions | ISO | RGD:1305476 | 6480464 | Copper inhibits the reaction [[diisopropanolnitrosamine co-treated with Propylthiouracil] results in increased expression of MKI67 protein]; more ... | CTD | PMID:19497425 |
| copper(0) | multiple interactions | ISO | RGD:1313525 | 6480464 | [NSC 689534 binds to Copper] which results in decreased expression of MKI67 mRNA | CTD | PMID:20971185 |
| copper(2+) sulfate | affects expression | ISO | RGD:1313525 | 6480464 | Copper Sulfate affects the expression of MKI67 mRNA | CTD | PMID:19549813 |
| coumestrol | increases expression | ISO | RGD:1313525 | 6480464 | Coumestrol results in increased expression of MKI67 mRNA | CTD | PMID:19167446 |
| coumestrol | multiple interactions | ISO | RGD:1313525 | 6480464 | [Coumestrol co-treated with ESR1 protein] results in increased expression of MKI67 mRNA; more ... | CTD | PMID:18310284 |
| coumestrol | multiple interactions | ISO | RGD:1313525 | 6480464 | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MKI67 mRNA; more ... | CTD | PMID:19167446 |
| curcumin | decreases expression | ISO | RGD:1313525 | 6480464 | Curcumin results in decreased expression of MKI67 protein | CTD | PMID:19372569 PMID:18226269 |
| curcumin | decreases expression | ISO | RGD:1313525 | 6480464 | Curcumin results in decreased expression of MKI67 protein | CTD | PMID:18226269 PMID:19372569 |
| curcumin | multiple interactions | EXP | | 6480464 | [Curcumin co-treated with gemcitabine] results in decreased expression of MKI67 protein | CTD | PMID:17440100 |
| cyclosporin A | decreases expression | ISO | RGD:1313525 | 6480464 | Cyclosporine results in decreased expression of MKI67 mRNA | CTD | PMID:20106945 |
| cyclosporin A | decreases expression | EXP | | 6480464 | Cyclosporine results in decreased expression of MKI67 mRNA | CTD | PMID:17942131 PMID:19770486 |
| cyclosporin A | decreases expression | ISO | RGD:1313525 | 6480464 | Cyclosporine results in decreased expression of MKI67 mRNA | CTD | PMID:19159671 more ... |
| cyclosporin A | decreases expression | EXP | | 6480464 | Cyclosporine results in decreased expression of MKI67 mRNA | CTD | PMID:19770486 PMID:17942131 |
| cyclosporin A | decreases expression | EXP | | 6480464 | Cyclosporine results in decreased expression of MKI67 mRNA | CTD | PMID:17942131 |
| dasatinib (anhydrous) | decreases expression | ISO | RGD:1313525 | 6480464 | dasatinib results in decreased expression of MKI67 mRNA | CTD | PMID:20579391 |
| dasatinib (anhydrous) | decreases expression | ISO | RGD:1313525 | 6480464 | dasatinib results in decreased expression of MKI67 protein | CTD | PMID:20682659 |
| dexamethasone | decreases expression | ISO | RGD:1313525 | 6480464 | Dexamethasone results in decreased expression of MKI67 protein | CTD | PMID:22048647 |
| dextran sulfate | multiple interactions | ISO | RGD:1305476 | 6480464 | [Azoxymethane co-treated with Dextran Sulfate] results in increased expression of MKI67 protein; more ... | CTD | PMID:19028472 |
| dibenzo[a,l]pyrene | decreases expression | ISO | RGD:1313525 | 6480464 | dibenzo(a,l)pyrene results in decreased expression of MKI67 mRNA | CTD | PMID:16269432 |
| dibutyl phthalate | decreases expression | ISO | RGD:1305476 | 6480464 | Dibutyl Phthalate results in decreased expression of MKI67 mRNA | CTD | PMID:21266533 |
| dibutyl phthalate | increases expression | ISO | RGD:1305476 | 6480464 | Dibutyl Phthalate results in increased expression of MKI67 protein | CTD | PMID:16916955 |
| diethyl maleate | increases expression | ISO | RGD:1305476 | 6480464 | diethyl maleate results in increased expression of MKI67 mRNA | CTD | PMID:21161181 |
| diethylstilbestrol | increases expression | EXP | | 6480464 | Diethylstilbestrol results in increased expression of MKI67 protein | CTD | PMID:16468032 |
| dioxygen | increases expression | EXP | | 6480464 | Oxygen deficiency results in increased expression of MKI67 mRNA | CTD | PMID:22629407 |
| dioxygen | multiple interactions | EXP | | 6480464 | Oxygen inhibits the reaction [Oxygen deficiency results in increased expression of MKI67 mRNA] | CTD | PMID:22629407 |
| doxorubicin | decreases expression | ISO | RGD:1313525 | 6480464 | Doxorubicin results in decreased expression of MKI67 mRNA | CTD | PMID:15205334 |
| doxorubicin | multiple interactions | ISO | RGD:1313525 | 6480464 | [zoledronic acid co-treated with Doxorubicin] results in decreased expression of MKI67 protein | CTD | PMID:18695136 |
| ethanol | decreases expression | ISO | RGD:1305476 | 6480464 | Ethanol results in decreased expression of MKI67 protein | CTD | PMID:17067360 |
| exemestane | decreases expression | ISO | RGD:1313525 | 6480464 | exemestane results in decreased expression of MKI67 protein | CTD | PMID:16002280 |
| fenofibrate | increases expression | ISO | RGD:1305476 | 6480464 | Fenofibrate results in increased expression of MKI67 protein | CTD | PMID:17264098 |
| folic acid | multiple interactions | EXP | | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of MKI67 mRNA | CTD | PMID:20938992 |
| fulvestrant | multiple interactions | EXP | | 6480464 | fulvestrant inhibits the reaction [1,7-diphenyl-5-heptene-3-one results in increased expression of MKI67 protein]; more ... | CTD | PMID:19654927 |
| furan | increases expression | ISO | RGD:1305476 | 6480464 | furan results in increased expression of MKI67 mRNA | CTD | PMID:20562052 |
| furan | increases expression | ISO | RGD:1305476 | 6480464 | furan results in increased expression of MKI67 protein | CTD | PMID:22507866 |
| genistein | multiple interactions | ISO | RGD:1305476 | 6480464 | Isoflavones inhibits the reaction [Genistein results in increased expression of MKI67 mRNA] | CTD | PMID:20381596 |
| genistein | increases expression | ISO | RGD:1305476 | 6480464 | Genistein results in increased expression of MKI67 mRNA | CTD | PMID:20381596 |
| hydroquinone O-beta-D-glucopyranoside | increases expression | ISO | RGD:1313525 | 6480464 | Arbutin results in increased expression of MKI67 mRNA | CTD | PMID:17103032 |
| indomethacin | multiple interactions | ISO | RGD:1305476 | 6480464 | Indomethacin inhibits the reaction [[Sulfadimethoxine co-treated with diisopropanolnitrosamine] results in increased expression of MKI67 protein]; more ... | CTD | PMID:22387750 |
| ketamine | increases expression | ISO | RGD:1313525 | 6480464 | Ketamine results in increased expression of MKI67 protein | CTD | PMID:19919587 |
| L-ascorbic acid | multiple interactions | ISO | RGD:1313525 | 6480464 | [Quercetin co-treated with Ascorbic Acid] results in increased expression of MKI67 mRNA | CTD | PMID:17639512 |
| L-methionine | multiple interactions | EXP | | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of MKI67 mRNA | CTD | PMID:20938992 |
| letrozole | decreases expression | ISO | RGD:1313525 | 6480464 | letrozole results in decreased expression of MKI67 protein | CTD | PMID:16002280 |
| levonorgestrel | decreases expression | ISO | RGD:1313525 | 6480464 | Levonorgestrel results in decreased expression of MKI67 protein | CTD | PMID:16019350 |
| linezolid | decreases expression | ISO | RGD:1305476 | 6480464 | linezolid results in decreased expression of MKI67 mRNA | CTD | PMID:21296123 |
| lithium atom | increases expression | ISO | RGD:1305476 | 6480464 | Lithium results in increased expression of MKI67 mRNA | CTD | PMID:21711903 |
| lithium chloride | multiple interactions | EXP | | 6480464 | Lithium Chloride inhibits the reaction [Progesterone inhibits the reaction [Estradiol results in increased expression of MKI67 protein]] | CTD | PMID:15845746 |
| lucanthone | decreases expression | ISO | RGD:1313525 | 6480464 | Lucanthone results in decreased expression of MKI67 mRNA | CTD | PMID:21148553 |
| lupeol | decreases expression | EXP | | 6480464 | lupeol results in decreased expression of MKI67 mRNA | CTD | PMID:20732907 |
| melatonin | multiple interactions | ISO | RGD:1305476 | 6480464 | Melatonin inhibits the reaction [[Azoxymethane co-treated with Dextran Sulfate] results in increased expression of MKI67 protein] | CTD | PMID:19028472 |
| melatonin | decreases expression | ISO | RGD:1313525 | 6480464 | Melatonin results in decreased expression of MKI67 protein; more ... | CTD | PMID:21062352 |
| methyl salicylate | affects expression | EXP | | 6480464 | methyl salicylate affects the expression of MKI67 mRNA | CTD | PMID:22302311 |
| mifepristone | decreases expression | ISO | RGD:1313525 | 6480464 | Mifepristone results in decreased expression of MKI67 protein | CTD | PMID:18579510 |
| monocrotaline | multiple interactions | EXP | | 6480464 | [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC gene mutant form] results in increased expression of MKI67 protein | CTD | PMID:21224054 |
| N-nitrosodiethylamine | increases expression | EXP | | 6480464 | Diethylnitrosamine results in increased expression of MKI67 mRNA | CTD | PMID:17854601 |
| N-nitrosodiethylamine | increases expression | ISO | RGD:1313525 | 6480464 | Diethylnitrosamine results in increased expression of MKI67 protein | CTD | PMID:21776270 |
| N-nitrosodiethylamine | multiple interactions | ISO | RGD:1305476 | 6480464 | [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of MKI67 protein | CTD | PMID:17651763 |
| N-nitrosodiethylamine | multiple interactions | ISO | RGD:1305476 | 6480464 | [Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of MKI67 protein; more ... | CTD | PMID:17393424 |
| N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of MKI67 protein] | CTD | PMID:17942915 |
| N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | RB1 protein inhibits the reaction [Diethylnitrosamine results in increased expression of MKI67 mRNA] | CTD | PMID:17854601 |
| N-nitrosodiethylamine | increases expression | EXP | | 6480464 | Diethylnitrosamine results in increased expression of MKI67 protein | CTD | PMID:17942915 |
| nickel sulfate | increases expression | ISO | RGD:1313525 | 6480464 | nickel sulfate results in increased expression of MKI67 protein | CTD | PMID:21776270 |
| nimesulide | multiple interactions | ISO | RGD:1305476 | 6480464 | nimesulide inhibits the reaction [[Sulfadimethoxine co-treated with diisopropanolnitrosamine] results in increased expression of MKI67 protein] | CTD | PMID:22387750 |
| nonanoic acid | affects expression | EXP | | 6480464 | pelargonic acid affects the expression of MKI67 mRNA | CTD | PMID:22302311 |
| ochratoxin A | decreases expression | ISO | RGD:1305476 | 6480464 | ochratoxin A results in decreased expression of MKI67 mRNA | CTD | PMID:21703336 |
| ochratoxin A | multiple interactions | ISO | RGD:1305476 | 6480464 | SHH protein modified form inhibits the reaction [ochratoxin A results in decreased expression of MKI67 mRNA] | CTD | PMID:21703336 |
| ozone | multiple interactions | EXP | | 6480464 | TTPA protein affects the reaction [Ozone results in increased expression of MKI67 mRNA] | CTD | PMID:19555225 |
| paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of MKI67 mRNA | CTD | PMID:17942131 |
| paracetamol | increases expression | ISO | RGD:1313525 | 6480464 | Acetaminophen results in increased expression of MKI67 mRNA | CTD | PMID:22230336 |
| paracetamol | increases expression | ISO | RGD:1305476 | 6480464 | Acetaminophen results in increased expression of MKI67 protein | CTD | PMID:17431590 |
| parathion-methyl | decreases expression | ISO | RGD:1313525 | 6480464 | Methyl Parathion results in decreased expression of MKI67 protein | CTD | PMID:18418871 |
| phenethyl isothiocyanate | decreases expression | ISO | RGD:1305476 | 6480464 | phenethyl isothiocyanate results in decreased expression of MKI67 mRNA | CTD | PMID:17616710 |
| phenobarbital | multiple interactions | EXP | | 6480464 | NR1I3 protein affects the reaction [Phenobarbital results in increased expression of MKI67 mRNA] | CTD | PMID:19482888 |
| phenobarbital | increases expression | EXP | | 6480464 | Phenobarbital results in increased expression of MKI67 mRNA | CTD | PMID:19363144 more ... |
| phenobarbital | increases expression | EXP | | 6480464 | Phenobarbital results in increased expression of MKI67 mRNA | CTD | PMID:19363144 more ... |
| phenobarbital | increases expression | EXP | | 6480464 | Phenobarbital results in increased expression of MKI67 mRNA | CTD | PMID:19482888 more ... |
| phenobarbital | increases expression | EXP | | 6480464 | Phenobarbital results in increased expression of MKI67 mRNA | CTD | PMID:19482888 more ... |
| phenobarbital | multiple interactions | ISO | RGD:1305476 | 6480464 | [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of MKI67 protein | CTD | PMID:17651763 |
| phenobarbital | increases expression | EXP | | 6480464 | Phenobarbital results in increased expression of MKI67 mRNA | CTD | PMID:20403969 more ... |
| phenytoin | multiple interactions | EXP | | 6480464 | [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC gene mutant form] results in increased expression of MKI67 protein | CTD | PMID:21224054 |
| phorbol 13-acetate 12-myristate | increases expression | EXP | | 6480464 | Tetradecanoylphorbol Acetate results in increased expression of MKI67 protein | CTD | PMID:22981962 |
| phthalaldehyde | affects expression | EXP | | 6480464 | o-Phthalaldehyde affects the expression of MKI67 mRNA | CTD | PMID:22302311 |
| pirinixic acid | increases expression | EXP | | 6480464 | pirinixic acid results in increased expression of MKI67 mRNA | CTD | PMID:17950772 |
| pirinixic acid | increases expression | ISO | RGD:1305476 | 6480464 | pirinixic acid results in increased expression of MKI67 mRNA | CTD | PMID:22484513 |
| pirinixic acid | multiple interactions | EXP | | 6480464 | PPARA protein promotes the reaction [pirinixic acid results in increased expression of MKI67 mRNA] | CTD | PMID:17950772 |
| piroxicam | decreases expression | ISO | RGD:1313525 | 6480464 | Piroxicam results in decreased expression of MKI67 mRNA | CTD | PMID:21858171 |
| pregnenolone 16alpha-carbonitrile | increases expression | EXP | | 6480464 | Pregnenolone Carbonitrile results in increased expression of MKI67 mRNA | CTD | PMID:22698814 |
| progesterone | increases expression | ISO | RGD:1313525 | 6480464 | Progesterone results in increased expression of MKI67 mRNA | CTD | PMID:16888808 |
| progesterone | multiple interactions | ISO | RGD:1305476 | 6480464 | [Estrogens co-treated with Progesterone] results in increased expression of MKI67 protein | CTD | PMID:16800253 |
| progesterone | affects expression | EXP | | 6480464 | Progesterone affects the expression of MKI67 mRNA | CTD | PMID:17251523 |
| progesterone | decreases expression | EXP | | 6480464 | Progesterone results in decreased expression of MKI67 mRNA | CTD | PMID:16966611 |
| progesterone | multiple interactions | EXP | | 6480464 | Lithium Chloride inhibits the reaction [Progesterone inhibits the reaction [Estradiol results in increased expression of MKI67 protein]] | CTD | PMID:15845746 |
| propiconazole | increases expression | EXP | | 6480464 | propiconazole results in increased expression of MKI67 mRNA | CTD | PMID:21278054 |
| propiconazole | increases expression | EXP | | 6480464 | propiconazole results in increased expression of MKI67 protein | CTD | PMID:22334560 |
| quercetin | multiple interactions | ISO | RGD:1313525 | 6480464 | [Quercetin co-treated with Ascorbic Acid] results in increased expression of MKI67 mRNA | CTD | PMID:17639512 |
| quercetin | decreases expression | EXP | | 6480464 | Quercetin results in decreased expression of MKI67 protein | CTD | PMID:15067354 |
| quercetin | multiple interactions | EXP | | 6480464 | Quercetin promotes the reaction [Tamoxifen results in decreased expression of MKI67 protein] | CTD | PMID:15067354 |
| raloxifene | decreases expression | ISO | RGD:1313525 | 6480464 | Raloxifene results in decreased expression of MKI67 protein | CTD | PMID:11535548 |
| resveratrol | decreases expression | ISO | RGD:1313525 | 6480464 | resveratrol results in decreased expression of MKI67 mRNA | CTD | PMID:15767336 |
| resveratrol | decreases expression | ISO | RGD:1313525 | 6480464 | resveratrol results in decreased expression of MKI67 protein | CTD | PMID:17992120 PMID:21209944 |
| resveratrol | multiple interactions | ISO | RGD:1313525 | 6480464 | [Coumestrol co-treated with resveratrol] results in increased expression of MKI67 mRNA | CTD | PMID:19167446 |
| resveratrol | increases expression | EXP | | 6480464 | resveratrol results in increased expression of MKI67 protein | CTD | PMID:22086758 |
| resveratrol | increases expression | ISO | RGD:1313525 | 6480464 | resveratrol results in increased expression of MKI67 mRNA | CTD | PMID:15149879 |
| resveratrol | decreases expression | ISO | RGD:1313525 | 6480464 | resveratrol results in decreased expression of MKI67 protein | CTD | PMID:17992120 |
| rifampicin | multiple interactions | EXP | | 6480464 | [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC gene mutant form] results in increased expression of MKI67 protein | CTD | PMID:21224054 |
| rosiglitazone | decreases expression | ISO | RGD:1313525 | 6480464 | rosiglitazone results in decreased expression of MKI67 protein | CTD | PMID:19955217 |
| Se-methyl-L-selenocysteine | multiple interactions | ISO | RGD:1313525 | 6480464 | [selenomethylselenocysteine co-treated with Tamoxifen] results in decreased expression of MKI67 protein | CTD | PMID:18855134 |
| Se-methyl-L-selenocysteine | decreases expression | ISO | RGD:1313525 | 6480464 | selenomethylselenocysteine results in decreased expression of MKI67 protein | CTD | PMID:18855134 |
| Se-methylselenocysteine | multiple interactions | ISO | RGD:1313525 | 6480464 | [selenomethylselenocysteine co-treated with Tamoxifen] results in decreased expression of MKI67 protein | CTD | PMID:18855134 |
| Se-methylselenocysteine | decreases expression | ISO | RGD:1313525 | 6480464 | selenomethylselenocysteine results in decreased expression of MKI67 protein | CTD | PMID:18855134 |
| sirolimus | decreases expression | ISO | RGD:1313525 | 6480464 | Sirolimus results in decreased expression of MKI67 protein | CTD | PMID:19773376 |
| sirolimus | multiple interactions | ISO | RGD:1313525 | 6480464 | [ABT-737 co-treated with Sirolimus] results in decreased expression of MKI67 protein | CTD | PMID:19773376 |
| sodium dichromate | decreases expression | ISO | RGD:1305476 | 6480464 | sodium bichromate results in decreased expression of MKI67 mRNA | CTD | PMID:22561333 |
| succimer | multiple interactions | EXP | | 6480464 | [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of MKI67 mRNA | CTD | PMID:21641980 |
| sulfadimethoxine | multiple interactions | ISO | RGD:1305476 | 6480464 | Indomethacin inhibits the reaction [[Sulfadimethoxine co-treated with diisopropanolnitrosamine] results in increased expression of MKI67 protein]; more ... | CTD | PMID:22387750 |
| sulfadimethoxine | increases expression | ISO | RGD:1305476 | 6480464 | Sulfadimethoxine results in increased expression of MKI67 protein | CTD | PMID:22387750 |
| tamoxifen | multiple interactions | ISO | RGD:1313525 | 6480464 | [selenomethylselenocysteine co-treated with Tamoxifen] results in decreased expression of MKI67 protein | CTD | PMID:18855134 |
| tamoxifen | decreases expression | ISO | RGD:1313525 | 6480464 | Tamoxifen results in decreased expression of MKI67 protein | CTD | PMID:16002280 more ... |
| tamoxifen | decreases expression | ISO | RGD:1313525 | 6480464 | Tamoxifen results in decreased expression of MKI67 protein | CTD | PMID:15767642 more ... |
| tamoxifen | decreases expression | ISO | RGD:1313525 | 6480464 | Tamoxifen results in decreased expression of MKI67 protein | CTD | PMID:16002280 more ... |
| tamoxifen | decreases expression | ISO | RGD:1313525 | 6480464 | Tamoxifen results in decreased expression of MKI67 protein | CTD | PMID:20332317 more ... |
| tamoxifen | decreases expression | ISO | RGD:1313525 | 6480464 | Tamoxifen results in decreased expression of MKI67 protein | CTD | PMID:20332317 more ... |
| tamoxifen | increases expression | ISO | RGD:1305476 | 6480464 | Tamoxifen results in increased expression of MKI67 protein | CTD | PMID:17219426 |
| tamoxifen | multiple interactions | ISO | RGD:1313525 | 6480464 | [Tamoxifen co-treated with anastrozole] results in decreased expression of MKI67 protein | CTD | PMID:15767642 |
| tamoxifen | decreases expression | ISO | RGD:1313525 | 6480464 | Tamoxifen results in decreased expression of MKI67 protein | CTD | PMID:15767642 more ... |
| tamoxifen | increases expression | ISO | RGD:1313525 | 6480464 | Tamoxifen results in increased expression of MKI67 protein | CTD | PMID:12627041 |
| tamoxifen | decreases expression | EXP | | 6480464 | Tamoxifen results in decreased expression of MKI67 protein | CTD | PMID:15067354 |
| tamoxifen | multiple interactions | EXP | | 6480464 | Quercetin promotes the reaction [Tamoxifen results in decreased expression of MKI67 protein] | CTD | PMID:15067354 |
| testosterone | multiple interactions | ISO | RGD:1313525 | 6480464 | [Testosterone co-treated with Calcitriol] results in decreased expression of MKI67 mRNA | CTD | PMID:21592394 |
| testosterone | decreases expression | ISO | RGD:1313525 | 6480464 | Testosterone results in decreased expression of MKI67 mRNA | CTD | PMID:21592394 |
| tetrachloromethane | affects expression | EXP | | 6480464 | Carbon Tetrachloride affects the expression of MKI67 mRNA | CTD | PMID:17484886 |
| tetrachloromethane | increases expression | ISO | RGD:1305476 | 6480464 | Carbon Tetrachloride results in increased expression of MKI67 protein | CTD | PMID:16325526 |
| thalidomide | multiple interactions | ISO | RGD:1313525 | 6480464 | [Azacitidine co-treated with Thalidomide] affects the expression of MKI67 mRNA | CTD | PMID:18720364 |
| tolbutamide | decreases expression | ISO | RGD:1305476 | 6480464 | Tolbutamide results in decreased expression of MKI67 protein | CTD | PMID:16718685 |
| trans-resveratrol | decreases expression | ISO | RGD:1313525 | 6480464 | resveratrol results in decreased expression of MKI67 mRNA | CTD | PMID:15767336 |
| trans-resveratrol | decreases expression | ISO | RGD:1313525 | 6480464 | resveratrol results in decreased expression of MKI67 protein | CTD | PMID:17992120 PMID:21209944 |
| trans-resveratrol | multiple interactions | ISO | RGD:1313525 | 6480464 | [Coumestrol co-treated with resveratrol] results in increased expression of MKI67 mRNA | CTD | PMID:19167446 |
| trans-resveratrol | increases expression | EXP | | 6480464 | resveratrol results in increased expression of MKI67 protein | CTD | PMID:22086758 |
| trans-resveratrol | increases expression | ISO | RGD:1313525 | 6480464 | resveratrol results in increased expression of MKI67 mRNA | CTD | PMID:15149879 |
| trans-resveratrol | decreases expression | ISO | RGD:1313525 | 6480464 | resveratrol results in decreased expression of MKI67 protein | CTD | PMID:17992120 |
| triamcinolone acetonide | decreases expression | ISO | RGD:1313525 | 6480464 | Triamcinolone Acetonide results in decreased expression of MKI67 protein | CTD | PMID:16029572 |
| trimellitic anhydride | increases expression | EXP | | 6480464 | trimellitic anhydride results in increased expression of MKI67 mRNA | CTD | PMID:19042947 |
| trimellitic anhydride | affects expression | EXP | | 6480464 | trimellitic anhydride affects the expression of MKI67 mRNA | CTD | PMID:22302311 |
| troglitazone | decreases expression | ISO | RGD:1313525 | 6480464 | troglitazone results in decreased expression of MKI67 mRNA | CTD | PMID:19140230 |
| troglitazone | increases expression | ISO | RGD:1313525 | 6480464 | troglitazone results in increased expression of MKI67 protein | CTD | PMID:10097144 |
| urethane | multiple interactions | EXP | | 6480464 | CYP2E1 gene mutant form inhibits the reaction [Urethane affects the expression of MKI67 protein] | CTD | PMID:15790490 |
| urethane | affects expression | EXP | | 6480464 | Urethane affects the expression of MKI67 protein | CTD | PMID:15790490 |
| vanadium atom | multiple interactions | ISO | RGD:1305476 | 6480464 | Vanadium inhibits the reaction [2-Acetylaminofluorene results in increased expression of MKI67 protein] | CTD | PMID:15565650 |
| vanadium(0) | multiple interactions | ISO | RGD:1305476 | 6480464 | Vanadium inhibits the reaction [2-Acetylaminofluorene results in increased expression of MKI67 protein] | CTD | PMID:15565650 |
| vincristine | increases response to substance | ISO | RGD:1313525 | 6480464 | MKI67 mRNA results in increased susceptibility to Vincristine | CTD | PMID:20864405 |
| zoledronic acid | multiple interactions | ISO | RGD:1313525 | 6480464 | [zoledronic acid co-treated with Doxorubicin] results in decreased expression of MKI67 protein | CTD | PMID:18695136 |